Litcius/Paper detail

Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease

Daniel C. Baumgart, Catherine Le Berre

2021New England Journal of Medicine347 citationsDOI

Abstract

There is still no cure for inflammatory bowel disease. This review covers newer treatments that reflect our understanding of the complex pathogenesis of IBD, with a focus on clinical and endoscopic remission and more precise molecular targeting of inflammatory cascades.

Topics & Concepts

MedicineInflammatory bowel diseaseInflammatory Bowel DiseasesPathogenesisDiseaseCrohn's diseaseIntensive care medicineImmunologyBioinformaticsPathologyBiologyInflammatory Bowel DiseaseImmunodeficiency and Autoimmune DisordersEosinophilic Esophagitis